WA HB1422

Modifies annual reporting requirements for drug take-back program operators to include itemized annual expenditures, estimated budgets for the next year, and explanations for unmet collection and public awareness goals

Requires the Department of Health to evaluate reports for compliance and request revisions within 30 days, including explanations for discrepancies between reported collection weights

Changes fee structure so annual fees are split evenly among approved program operators, with total fees capped at 10% of the highest single operator's annual expenditures rather than each program's individual expenditures

Imposes a one-time $70,000 fee (split among program operators) to fund a Joint Legislative Audit and Review Committee expedited review of the department's fee-setting authority, due by December 31, 2025

Sets an automatic repeal date of January 1, 2030 for the drug take-back program statutes under chapter 69.48 RCW